Brazil lifts ban on controversial sterilization implants

July 11, 2017

Brazil has lifted a ban on the sale of Essure female sterilization implants after receiving results from clinical trials on its risks, authorities said Tuesday.

Sale of the implants, which was suspended in February, was authorized after its maker Bayer presented documents detailing that had been sought by the Brazilian Health Regulatory Agency (Anvisa).

These included results of that lasted a year or longer as well as a report on measures taken by the maker after a warning by Canada's health agency.

The so-called "permanent birth control" method involves the implantation of a metal coil in each fallopian tube which leads to the build-up of that forms a barrier preventing sperm from reaching eggs.

Acquired by German pharmaceutical firm Bayer in 2013, its use is being scrutinized by a number of countries, including the United States and France since 2015 following a surge of complaints about side effects.

About one million units have been sold worldwide since 2001.

Anvisa said its earlier suspension was brought about by the company's failure to respond to concerns on the product's safety.

Side effects can include changes to the menstrual cycle, unwanted pregnancies, chronic pain, perforations of the uterus and , migration of the device to the abdominal or pelvic cavity and suspected allergic or .

A collective lawsuit against Bayer is set to be filed in France in September by a group of 400 women, a lawyer representing them told AFP, while a Facebook group called "Essure Problems" currently counts more than 33,000 members.

Explore further: Women sue healthcare giant Bayer over contraceptive implants

Related Stories

Women sue healthcare giant Bayer over contraceptive implants

December 9, 2016
French lawyers for women who say a contraceptive implant sold by Bayer Healthcare had caused a string of medical complications launched a lawsuit against the multinational on Friday.

FDA reviewing safety of Essure birth control implant

June 25, 2015
Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.

FDA explains pros, cons of permanent birth control

November 18, 2016
(HealthDay)—Women need to carefully consider the benefits and risks of permanent birth control devices, the U.S. Food and Drug Administration says.

FDA experts to review safety of Essure birth control implant

September 21, 2015
Federal medical experts will take a closer look at a host of problems reported with the birth control implant called Essure, including chronic pain, bleeding, headaches and allergic reactions.

FDA aims to publish Essure safety review in February

November 24, 2015
Federal health officials aim to release their findings on a much-debated contraceptive implant by the end of February.

FDA petitioned to stop sales of essure implant

May 5, 2015
(HealthDay)—Bayer's contraceptive implant Essure can cause serious complications and should be taken off the market, says a citizen's petition filed with the U.S. Food and Drug Administration.

Recommended for you

Women exposed to smoke while in womb more likely to miscarry

July 13, 2017
Women exposed to cigarette smoke while in their mothers' wombs are more likely to experience miscarriage as adults, according to new research from the University of Aberdeen.

Lack of a hormone in pregnant mice linked to preeclampsia

June 30, 2017
(Medical Xpress)—A team of researchers from Singapore, the Netherlands and Turkey has isolated a hormone in pregnant mice that appears to be associated with preeclampsia—a pregnancy-related condition characterized by ...

Aspirin reduces risk of pre-eclampsia in pregnant women

June 28, 2017
Taking a low-dose aspirin before bed can reduce the risk of pre-eclampsia, which can cause premature birth and, in extreme cases, maternal and foetal death.

The biology of uterine fluid: How it informs the fetus of mom's world

June 22, 2017
A developing fetus bathes in a mixture of cellular secretions and proteins unique to its mother's uterus. Before fertilization, the pH of uterine fluid helps create a conducive environment for sperm migration, and afterward, ...

New clues in puzzle over pre-eclampsia and cholesterol regulation

June 21, 2017
Scientists studying a mystery link between the dangerous pregnancy complication pre-eclampsia and an increased risk of heart disease in later life for both mother and child have uncovered important new clues.

Are maternal hormones different when carrying a boy or a girl?

June 15, 2017
With advances in prenatal testing it's now possible to find out whether a pregnancy will result in a male or female baby as early as eight weeks' gestation.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.